[Progress in prediction and recovery of immunosuppressive therapy in patients with severe aplastic anemia].
作者信息
Ding S X, Fu R
机构信息
Tianjin Medical University General Hospital, Tianjin 300052, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2018 Nov 14;39(11):960-964. doi: 10.3760/cma.j.issn.0253-2727.2018.11.019.
Abstract
摘要
相似文献
1
[Progress in prediction and recovery of immunosuppressive therapy in patients with severe aplastic anemia].[重型再生障碍性贫血患者免疫抑制治疗的预测与恢复进展]
Zhonghua Xue Ye Xue Za Zhi. 2018 Nov 14;39(11):960-964. doi: 10.3760/cma.j.issn.0253-2727.2018.11.019.
2
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.与一线使用环孢素和/或抗胸腺细胞或抗淋巴细胞球蛋白治疗获得性重型再生障碍性贫血相比，HLA匹配的同胞供者进行一线异基因造血干细胞移植的情况。
Cochrane Database Syst Rev. 2013 Jul 23;2013(7):CD006407. doi: 10.1002/14651858.CD006407.pub2.
3
[Immunosuppressive therapy for 54 children patients with acquired severe aplastic anemia].54例儿童获得性重型再生障碍性贫血的免疫抑制治疗
Zhonghua Er Ke Za Zhi. 2006 Nov;44(11):841-4.
4
Relapse of aplastic anemia in children after immunosuppressive therapy: a report from the Japan Childhood Aplastic Anemia Study Group.儿童再生障碍性贫血免疫抑制治疗后复发：来自日本儿童再生障碍性贫血研究组的报告。
Haematologica. 2011 Jun;96(6):814-9. doi: 10.3324/haematol.2010.035600. Epub 2011 Mar 21.
5
First-line treatment for severe aplastic anemia in children: bone marrow transplantation from a matched family donor versus immunosuppressive therapy.儿童重型再生障碍性贫血的一线治疗：来自匹配家族供体的骨髓移植与免疫抑制治疗对比。
Haematologica. 2014 Dec;99(12):1784-91. doi: 10.3324/haematol.2014.109355. Epub 2014 Sep 5.
6
Reactive Plasmacytosis Immediately After Immunosuppressive Therapy With Anti-human Thymocyte Immunoglobulin for Severe Aplastic Anemia: A Report of a Rare Case.抗人胸腺细胞免疫球蛋白治疗重型再生障碍性贫血后即刻出现的反应性浆细胞增多症：1例罕见病例报告
Cureus. 2024 Mar 30;16(3):e57255. doi: 10.7759/cureus.57255. eCollection 2024 Mar.
7
Association of the interferon-gamma single nucleotide polymorphism +874(T/A) with response to immunosuppressive therapy in patients with severe aplastic anemia.干扰素-γ 单核苷酸多态性+874(T/A)与重型再生障碍性贫血患者免疫抑制治疗反应的相关性。
Blood Cells Mol Dis. 2010 Dec 15;45(4):313-6. doi: 10.1016/j.bcmd.2010.09.003. Epub 2010 Oct 12.
8
Malignant tumors occurring after treatment of aplastic anemia. European Bone Marrow Transplantation-Severe Aplastic Anaemia Working Party.再生障碍性贫血治疗后发生的恶性肿瘤。欧洲骨髓移植-重型再生障碍性贫血工作组。
N Engl J Med. 1993 Oct 14;329(16):1152-7. doi: 10.1056/NEJM199310143291603.
9
Effectiveness of immunosuppressive therapy in older patients with aplastic anemia. European Group for Blood and Marrow Transplantation Severe Aplastic Anaemia Working Party.免疫抑制疗法对老年再生障碍性贫血患者的疗效。欧洲血液和骨髓移植组重型再生障碍性贫血工作组。
Ann Intern Med. 1999 Feb 2;130(3):193-201. doi: 10.7326/0003-4819-130-3-199902020-00004.
10
Immunosuppressive therapy for aplastic anemia: indications, agents, mechanisms, and results.再生障碍性贫血的免疫抑制治疗：适应证、药物、机制及结果
Am J Pediatr Hematol Oncol. 1990 Winter;12(4):411-24. doi: 10.1097/00043426-199024000-00005.
本文引用的文献
1
Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.全国范围内获得性再生障碍性贫血患者使用马抗胸腺细胞球蛋白（ATGAM）的调查：法国再生障碍性贫血参考中心报告。
Am J Hematol. 2018 May;93(5):635-642. doi: 10.1002/ajh.25050. Epub 2018 Feb 14.
2
Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications.体细胞 HLA 突变揭示了 I 类介导的自身免疫在再生障碍性贫血及其克隆性并发症中的作用。
Blood Adv. 2017 Oct 10;1(22):1900-1910. doi: 10.1182/bloodadvances.2017010918.
3
Telomere length and somatic mutations in correlation with response to immunosuppressive treatment in aplastic anaemia.再生障碍性贫血中端粒长度和体细胞突变与免疫抑制治疗反应的相关性
Br J Haematol. 2017 Aug;178(4):603-615. doi: 10.1111/bjh.14691. Epub 2017 Jul 12.
4
Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia.兔抗胸腺细胞球蛋白和马抗胸腺细胞球蛋白治疗再生障碍性贫血的荟萃分析。
Int J Hematol. 2017 May;105(5):578-586. doi: 10.1007/s12185-017-2179-3. Epub 2017 Jan 11.
5
Efficacy of combination therapy with anti-thymocyte globulin and cyclosporine A as a first-line treatment in adult patients with aplastic anemia: a comparison of rabbit and horse formulations.抗胸腺细胞球蛋白与环孢素A联合治疗作为成人再生障碍性贫血一线治疗的疗效：兔源制剂与马源制剂的比较
Int J Hematol. 2016 Oct;104(4):446-53. doi: 10.1007/s12185-016-2046-7. Epub 2016 Jun 23.
6
Deep phenotyping of Tregs identifies an immune signature for idiopathic aplastic anemia and predicts response to treatment.调节性T细胞的深度表型分析确定了再生障碍性贫血的免疫特征并预测治疗反应。
Blood. 2016 Sep 1;128(9):1193-205. doi: 10.1182/blood-2016-03-703702. Epub 2016 Jun 8.
7
Danazol Treatment for Telomere Diseases.达那唑治疗端粒疾病
N Engl J Med. 2016 May 19;374(20):1922-31. doi: 10.1056/NEJMoa1515319.
8
Clonal hematopoiesis in acquired aplastic anemia.获得性再生障碍性贫血中的克隆性造血
Blood. 2016 Jul 21;128(3):337-47. doi: 10.1182/blood-2016-01-636381. Epub 2016 Apr 27.
9
Markedly High Plasma Thrombopoietin (TPO) Level is a Predictor of Poor Response to Immunosuppressive Therapy in Children With Acquired Severe Aplastic Anemia.显著升高的血浆血小板生成素（TPO）水平是获得性重型再生障碍性贫血患儿免疫抑制治疗反应不佳的一个预测指标。
Pediatr Blood Cancer. 2016 Apr;63(4):659-64. doi: 10.1002/pbc.25820. Epub 2015 Nov 17.
10
Guidelines for the diagnosis and management of adult aplastic anaemia.成人再生障碍性贫血诊断与治疗指南。
Br J Haematol. 2016 Jan;172(2):187-207. doi: 10.1111/bjh.13853. Epub 2015 Nov 16.
Zotero 插件